Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AK0529 in Adult RSV Infection (Phase 2, China)
CTR20230657Phase 2Terminated
- Sponsor
- Aicobio
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ziresovir in respiratory syncytial virus disease (RSV), sponsored by Aicobio. Started Mar 2023; status: terminated.
02
Drugs
ziresovir
03
Conditions
respiratory syncytial virus disease (RSV)
Beyond the preview
Go deeper on CTR20230657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230657.